Opinion|Videos|September 22, 2023
Available Frontline Treatment Options for Patients With Advanced or Recurrent Endometrial Cancer
Author(s)Ramez N. Eskander, MD, Krishnansu Tewari, MD
Krishnansu Tewari, MD, details the first-line treatment options for patients with recurrent endometrial cancer.
Advertisement
Episodes in this series
Advertisement
Related to this article
CHMP has recommended EU approval of senaparib for advanced ovarian cancer based on FLAMES data.
Advertisement
Advertisement
Trending on OncLive
1
Revisit Every OncLive On Air Episode From September 2026
2
Optune Pax Is Approved in Japan for Unresectable Locally Advanced Pancreatic Cancer
3
Oral Azacitidine and Cedazuridine Meets Primary Pharmacokinetic End Point in MDS and CMML
4
UTRxMYCN M1-14 Nets FDA Dual Designations in Soft Tissue Sarcoma
5